Nociceptin Receptor as a Target to Treat Alcohol Use Disorder: Challenges in Advancing Medications Development.

IF 3.2 3区医学 Q1 Medicine

Alcoholism, clinical and experimental research Pub Date : 2016-10-01 DOI:10.1111/acer.13222

R. Litten

引用次数: 3

查看原文本刊更多论文

痛觉肽受体作为治疗酒精使用障碍的靶点:推进药物开发的挑战

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Alcoholism, clinical and experimental research 医学-药物滥用

CiteScore

5.90

自引率

9.40%

发文量

219

审稿时长

1 months

期刊介绍： Alcoholism: Clinical and Experimental Research''s scope spans animal and human clinical research, epidemiological, experimental, policy, and historical research relating to any aspect of alcohol abuse, dependence, or alcoholism. This journal uses a multi-disciplinary approach in its scope of alcoholism, its causes, clinical and animal effect, consequences, patterns, treatments and recovery, predictors and prevention.